Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF502 ZNF717 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 ZNF345 ZNF513 ZNF2	7.11e-08	1412	92	23	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF502 ZNF717 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZNF883 ZNF345 ZNF513 ZNF2	5.52e-07	1459	92	22	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF502 ZNF717 ZNF594 ZNF33A ZNF484 ZNF283 ZNF629 ZNF624 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZNF883 ZNF345 ZNF513 ZNF2	3.18e-06	1244	92	19	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF502 ZNF717 ZNF594 ZNF33A ZNF484 ZNF283 ZNF629 ZNF624 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZNF883 ZNF345 ZNF513 ZNF2	4.34e-06	1271	92	19	GO:0000987
GeneOntologyMolecularFunction	structural constituent of presynaptic active zone	RIMS1 RIMS2	5.77e-04	8	92	2	GO:0098882
GeneOntologyBiologicalProcess	positive regulation of inhibitory postsynaptic potential	NLGN3 RIMS1 RIMS2	9.75e-06	10	91	3	GO:0097151
GeneOntologyBiologicalProcess	modulation of inhibitory postsynaptic potential	NLGN3 RIMS1 RIMS2	1.78e-05	12	91	3	GO:0098828
GeneOntologyBiologicalProcess	positive regulation of excitatory postsynaptic potential	NLGN3 GRIP2 RIMS1 RIMS2	3.84e-05	43	91	4	GO:2000463
GeneOntologyCellularComponent	presynaptic cytoskeleton	FAM107A RIMS1 RIMS2	2.90e-05	14	92	3	GO:0099569
GeneOntologyCellularComponent	inhibitory synapse	NLGN3 RIMS1 RIMS2	3.39e-04	31	92	3	GO:0060077
GeneOntologyCellularComponent	cytoskeleton of presynaptic active zone	RIMS1 RIMS2	5.27e-04	8	92	2	GO:0048788
Domain	-	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	8.39e-16	679	90	25	3.30.160.60
Domain	Znf_C2H2/integrase_DNA-bd	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	1.39e-15	694	90	25	IPR013087
Domain	zf-C2H2	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	1.37e-14	693	90	24	PF00096
Domain	ZINC_FINGER_C2H2_2	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	1.73e-14	775	90	25	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	1.84e-14	777	90	25	PS00028
Domain	Znf_C2H2-like	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	3.18e-14	796	90	25	IPR015880
Domain	Znf_C2H2	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	4.10e-14	805	90	25	IPR007087
Domain	ZnF_C2H2	ZNF502 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	4.46e-14	808	90	25	SM00355
Domain	KRAB	ZNF33A ZNF484 ZNF436 ZNF283 ZNF343 ZNF624 ZKSCAN2 ZNF84 ZNF782 ZNF844 ZNF418 ZNF471 ZNF222 ZNF2	1.70e-09	358	90	14	PS50805
Domain	KRAB	ZNF33A ZNF484 ZNF436 ZNF283 ZNF343 ZNF624 ZKSCAN2 ZNF84 ZNF782 ZNF844 ZNF418 ZNF471 ZNF222 ZNF2	1.70e-09	358	90	14	PF01352
Domain	KRAB	ZNF33A ZNF484 ZNF436 ZNF283 ZNF343 ZNF624 ZKSCAN2 ZNF84 ZNF782 ZNF844 ZNF418 ZNF471 ZNF222 ZNF2	2.51e-09	369	90	14	SM00349
Domain	KRAB	ZNF33A ZNF484 ZNF436 ZNF283 ZNF343 ZNF624 ZKSCAN2 ZNF84 ZNF782 ZNF844 ZNF418 ZNF471 ZNF222 ZNF2	2.60e-09	370	90	14	IPR001909
Domain	zf-C2H2_6	ZNF502 ZNF283 ZNF624 ZNF84 ZNF782 ZNF844 ZNF418 ZNF883 ZNF345	2.05e-05	314	90	9	PF13912
Domain	ARM-type_fold	NF1 INTS7 ASPM AP1G2 HEATR5A VIRMA NCAPG2 HTT XPO7	3.73e-05	339	90	9	IPR016024
Domain	ARM-like	NF1 INTS7 ASPM AP1G2 HEATR5A NCAPG2 HTT XPO7	4.79e-05	270	90	8	IPR011989
Domain	-	NF1 INTS7 ASPM AP1G2 HEATR5A NCAPG2 HTT	9.87e-05	222	90	7	1.25.10.10
Domain	Znf_FYVE_PHD	TRIM66 ASH1L RIMS1 JADE1 RIMS2	7.25e-04	147	90	5	IPR011011
Domain	BAH	ORC1 ASH1L	1.23e-03	11	90	2	SM00439
Domain	BAH	ORC1 ASH1L	1.23e-03	11	90	2	PF01426
Domain	BAH	ORC1 ASH1L	1.23e-03	11	90	2	PS51038
Domain	FYVE_2	RIMS1 RIMS2	1.23e-03	11	90	2	PF02318
Domain	BAH_dom	ORC1 ASH1L	1.23e-03	11	90	2	IPR001025
Domain	RABBD	RIMS1 RIMS2	1.47e-03	12	90	2	PS50916
Domain	Rab_BD	RIMS1 RIMS2	1.47e-03	12	90	2	IPR010911
Domain	Zinc_finger_PHD-type_CS	TRIM66 ASH1L JADE1	3.81e-03	65	90	3	IPR019786
Domain	HEAT_REPEAT	HEATR5A NCAPG2 HTT	4.69e-03	70	90	3	PS50077
Domain	Pentatricopeptide_repeat	NCAPG2 HTT	5.44e-03	23	90	2	IPR002885
Domain	PHD	TRIM66 ASH1L JADE1	5.69e-03	75	90	3	PF00628
Domain	Znf_PHD-finger	TRIM66 ASH1L JADE1	6.57e-03	79	90	3	IPR019787
Domain	AT_hook	SETBP1 ASH1L	7.45e-03	27	90	2	SM00384
Domain	AT_hook_DNA-bd_motif	SETBP1 ASH1L	7.45e-03	27	90	2	IPR017956
Domain	FHA	SNIP1 CEP170B	8.00e-03	28	90	2	SM00240
Domain	Rho_GTPase_activation_prot	NF1 ARHGAP15 ARHGAP29	8.84e-03	88	90	3	IPR008936
Domain	PHD	TRIM66 ASH1L JADE1	9.12e-03	89	90	3	SM00249
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	USP53 USP8 ESYT2 VPS13D NF1 MTUS1 PRRC2C RALGAPB ZNF629 OSBPL10 TANC1 CKAP2 VIRMA CEP170B	7.10e-08	861	93	14	36931259
Pubmed	Isolation of cDNA clones for 42 different Krüppel-related zinc finger proteins expressed in the human monoblast cell line U-937.	ZNF594 ZNF283 ZNF83 ZNF345	2.77e-07	21	93	4	7865130
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	USP53 NLGN3 ESYT2 SGSM1 ZNF33A SETBP1 RALGAPB ASH1L CILK1 LINC02910 TANC1 ZNF84 RIMS1 CKAP2 CEP170B HTT XPO7	3.93e-07	1489	93	17	28611215
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	USP53 ASH1L ZNF624 HEATR5A ZNF471 VIRMA	3.65e-06	153	93	6	10718198
Pubmed	Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects.	NTM OPCML	7.07e-06	2	93	2	24616287
Pubmed	A presynaptic phosphosignaling hub for lasting homeostatic plasticity.	RIMS1 RIMS2	7.07e-06	2	93	2	35443170
Pubmed	RIM2α is a molecular scaffold for Zona pellucida-induced acrosome reaction.	RIMS1 RIMS2	7.07e-06	2	93	2	25240052
Pubmed	NF1 mutation drives neuronal activity-dependent initiation of optic glioma.	NLGN3 NF1	7.07e-06	2	93	2	34040258
Pubmed	RIM genes differentially contribute to organizing presynaptic release sites.	RIMS1 RIMS2	7.07e-06	2	93	2	22753485
Pubmed	Analysis of RIM Expression and Function at Mouse Photoreceptor Ribbon Synapses.	RIMS1 RIMS2	7.07e-06	2	93	2	28701482
Pubmed	Cloning of neurotrimin defines a new subfamily of differentially expressed neural cell adhesion molecules.	NTM OPCML	7.07e-06	2	93	2	7891157
Pubmed	RIM C2B Domains Target Presynaptic Active Zone Functions to PIP2-Containing Membranes.	RIMS1 RIMS2	7.07e-06	2	93	2	29606581
Pubmed	RIM1/2-Mediated Facilitation of Cav1.4 Channel Opening Is Required for Ca2+-Stimulated Release in Mouse Rod Photoreceptors.	RIMS1 RIMS2	7.07e-06	2	93	2	26400943
Pubmed	OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.	NTM OPCML	7.07e-06	2	93	2	12819783
Pubmed	The presynaptic active zone protein RIM1α controls epileptogenesis following status epilepticus.	RIMS1 RIMS2	7.07e-06	2	93	2	22956829
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L TRIM66 NLGN3 VPS13D SYNM ZNF436 ZNF629 CILK1 ZNF407	7.20e-06	493	93	9	15368895
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ESYT2 KANSL1 MTUS1 RALGAPB GRIP2	8.73e-06	103	93	5	10574462
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP8 KANSL1 PRRC2C RALGAPB HEATR5A VIRMA CEP170B XPO7	1.41e-05	407	93	8	12693553
Pubmed	RIM1 and RIM2 redundantly determine Ca2+ channel density and readily releasable pool size at a large hindbrain synapse.	RIMS1 RIMS2	2.12e-05	3	93	2	25343783
Pubmed	Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population.	VPS13D OSBPL10	2.12e-05	3	93	2	20610895
Pubmed	RIM is essential for stimulated but not spontaneous somatodendritic dopamine release in the midbrain.	RIMS1 RIMS2	2.12e-05	3	93	2	31486769
Pubmed	RIM determines Ca²+ channel density and vesicle docking at the presynaptic active zone.	RIMS1 RIMS2	2.12e-05	3	93	2	21262468
Pubmed	Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis.	RIMS1 RIMS2	2.12e-05	3	93	2	25730884
Pubmed	Rab3-interacting molecules 2α and 2β promote the abundance of voltage-gated CaV1.3 Ca2+ channels at hair cell active zones.	RIMS1 RIMS2	2.12e-05	3	93	2	26034270
Pubmed	Alternative splicing in the first alpha-helical region of the Rab-binding domain of Rim regulates Rab3A binding activity: is Rim a Rab3 effector protein during evolution?	RIMS1 RIMS2	2.12e-05	3	93	2	15330860
Pubmed	Selective optogenetic activation of NaV1.7-expressing afferents in NaV1.7-ChR2 mice induces nocifensive behavior without affecting responses to mechanical and thermal stimuli.	ESYT2 SCN9A	2.12e-05	3	93	2	36201719
Pubmed	C-terminal splice variants of P/Q-type Ca2+ channel CaV2.1 α1 subunits are differentially regulated by Rab3-interacting molecule proteins.	RIMS1 RIMS2	2.12e-05	3	93	2	28377503
Pubmed	RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction.	RIMS1 RIMS2	2.12e-05	3	93	2	21241895
Pubmed	Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex.	RIMS1 RIMS2	2.12e-05	3	93	2	25155955
Pubmed	Identification of a heteromeric complex that promotes DNA replication origin firing in human cells.	TOPBP1 MTBP	2.12e-05	3	93	2	23704573
Pubmed	The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers.	FASN MUC16	2.12e-05	3	93	2	32698888
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	ESYT2 VPS13D MTUS1 ARHGAP29 TANC1 CEP170B	2.16e-05	209	93	6	36779422
Pubmed	Protein composition of axonal dopamine release sites in the striatum.	RIMS1 RIMS2	4.23e-05	4	93	2	36579890
Pubmed	Divergent properties and independent regulation of striatal dopamine and GABA co-transmission.	RIMS1 RIMS2	4.23e-05	4	93	2	35584679
Pubmed	RIM proteins activate vesicle priming by reversing autoinhibitory homodimerization of Munc13.	RIMS1 RIMS2	4.23e-05	4	93	2	21262469
Pubmed	Dorsal root ganglia isolated from Nf1+/- mice exhibit increased levels of mRNA expression of voltage-dependent sodium channels.	NF1 SCN9A	4.23e-05	4	93	2	22260870
Pubmed	Members of the zinc finger protein gene family sharing a conserved N-terminal module.	ZNF84 ZNF2	4.23e-05	4	93	2	1945843
Pubmed	Rab3-interacting molecule gamma isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels.	RIMS1 RIMS2	4.23e-05	4	93	2	20452978
Pubmed	Genomic definition of RIM proteins: evolutionary amplification of a family of synaptic regulatory proteins.	RIMS1 RIMS2	4.23e-05	4	93	2	12620390
Pubmed	Fusion Competent Synaptic Vesicles Persist upon Active Zone Disruption and Loss of Vesicle Docking.	RIMS1 RIMS2	4.23e-05	4	93	2	27537483
Pubmed	Biallelic variants in TSPOAP1, encoding the active-zone protein RIMBP1, cause autosomal recessive dystonia.	RIMS1 RIMS2	7.04e-05	5	93	2	33539324
Pubmed	Thalamocortical control of cell-type specificity drives circuits for processing whisker-related information in mouse barrel cortex.	RIMS1 RIMS2	7.04e-05	5	93	2	37770450
Pubmed	An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury.	RIMS1 RIMS2	7.04e-05	5	93	2	34706221
Pubmed	Rim, a component of the presynaptic active zone and modulator of exocytosis, binds 14-3-3 through its N terminus.	RIMS1 RIMS2	7.04e-05	5	93	2	12871946
Pubmed	RIM1/2 in retinal ganglion cells are required for the refinement of ipsilateral axons and eye-specific segregation.	RIMS1 RIMS2	7.04e-05	5	93	2	28607399
Pubmed	A Trio of Active Zone Proteins Comprised of RIM-BPs, RIMs, and Munc13s Governs Neurotransmitter Release.	RIMS1 RIMS2	7.04e-05	5	93	2	32755572
Pubmed	Spatiotemporal expression of IgLON family members in the developing mouse nervous system.	NTM OPCML	7.04e-05	5	93	2	34599206
Pubmed	RIM, Munc13, and Rab3A interplay in acrosomal exocytosis.	RIMS1 RIMS2	7.04e-05	5	93	2	22248876
Pubmed	Neurotransmitter release at the thalamocortical synapse instructs barrel formation but not axon patterning in the somatosensory cortex.	RIMS1 RIMS2	7.04e-05	5	93	2	22553025
Pubmed	Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission.	RIMS1 RIMS2	7.04e-05	5	93	2	33139401
Pubmed	Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.	SECISBP2L ZNF142 LPIN2 TOPBP1	7.49e-05	83	93	4	9039502
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF502 SNIP1 ESYT2 FASN ZNF142 BCLAF1 ZNF436 ZNF283 ZNF629 ZNF407 VIRMA XPO7	8.76e-05	1203	93	12	29180619
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP53 MTUS1 BCLAF1 SETBP1 TOPBP1 HMGXB3 JADE1 RIMS2	8.92e-05	529	93	8	14621295
Pubmed	Identification of Wilms' tumor 1-associating protein complex and its role in alternative splicing and the cell cycle.	BCLAF1 VIRMA	1.05e-04	6	93	2	24100041
Pubmed	The human genome contains hundreds of genes coding for finger proteins of the Krüppel type.	ZNF84 ZNF83	1.05e-04	6	93	2	2505992
Pubmed	The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators.	RIMS1 RIMS2	1.05e-04	6	93	2	31679900
Pubmed	How to Make an Active Zone: Unexpected Universal Functional Redundancy between RIMs and RIM-BPs.	RIMS1 RIMS2	1.05e-04	6	93	2	27537484
Pubmed	cAMP-GEFII is a direct target of cAMP in regulated exocytosis.	RIMS1 RIMS2	1.05e-04	6	93	2	11056535
Pubmed	Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites.	RIMS1 RIMS2	1.47e-04	7	93	2	29398114
Pubmed	Synaptic, transcriptional and chromatin genes disrupted in autism.	RALGAPB ASH1L	1.47e-04	7	93	2	25363760
Pubmed	Rebuilding essential active zone functions within a synapse.	RIMS1 RIMS2	1.47e-04	7	93	2	35176221
Pubmed	Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.	CD5 TOPBP1	1.47e-04	7	93	2	18006695
Pubmed	Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones.	RIMS1 RIMS2	1.47e-04	7	93	2	36398873
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZNF436 ZNF407 TANC1 GRIP2	1.67e-04	102	93	4	11214970
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	TRIM66 SYNM ZNF629 RIMS1	1.80e-04	104	93	4	9205841
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	ESYT2 NF1 NCAPG2 HTT	1.80e-04	104	93	4	31240132
Pubmed	The Cdk8/19-cyclin C transcription regulator functions in genome replication through metazoan Sld7.	TOPBP1 MTBP	1.96e-04	8	93	2	30695077
Pubmed	A WD-repeat protein stabilizes ORC binding to chromatin.	ORC1 GMNN	1.96e-04	8	93	2	20932478
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	NF1 BCLAF1 ASPM CKAP2 NCAPG2	2.58e-04	210	93	5	16565220
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	ORC1 RALGAPB GRIP2 RIMS1 RIMS2 MEPE	2.62e-04	329	93	6	17474147
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	NF1 KANSL1 INTS7 PRRC2C BTBD10 SCN9A HTT	2.92e-04	475	93	7	31040226
Pubmed	Inhibition of eukaryotic DNA replication by geminin binding to Cdt1.	ORC1 GMNN	3.14e-04	10	93	2	11125146
Pubmed	A Y2H-seq approach defines the human protein methyltransferase interactome.	KANSL1 ARHGAP15 ZNF436 ARHGAP29 AP1G2 ZNF2	3.22e-04	342	93	6	23455924
Pubmed	Molecular and functional architecture of striatal dopamine release sites.	RIMS1 RIMS2	3.83e-04	11	93	2	34767769
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	BCLAF1 RIMS1 RIMS2 CEP170B FAM131B	4.00e-04	231	93	5	16452087
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NLGN3 FASN NF1 BCLAF1 PRRC2C NTM OSBPL10 TANC1 RIMS1 VIRMA CEP170B OPCML	4.31e-04	1431	93	12	37142655
Pubmed	A shared vesicular carrier allows synaptic corelease of GABA and glycine.	RIMS1 RIMS2	4.59e-04	12	93	2	16701208
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	ORC1 SNIP1 TRIM66 SGSM1 NF1 RALGAPB ASPM HMGXB3 VIRMA KIF24 GMNN	4.83e-04	1242	93	11	30973865
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	ORC1 FASN BCLAF1 TOPBP1 VIRMA NCAPG2	4.87e-04	370	93	6	22922362
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	MTUS1 CKAP2 CEP170B	4.88e-04	57	93	3	29089450
Pubmed	Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific.	SNIP1 ZNF594 CMYA5	5.40e-04	59	93	3	32031713
Pubmed	Global phosphoproteome of HT-29 human colon adenocarcinoma cells.	EPS8L2 NF1 BCLAF1	5.40e-04	59	93	3	16083285
Pubmed	A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling.	INTS7 TOPBP1	5.41e-04	13	93	2	21659603
Pubmed	Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.	BCLAF1 ASH1L	6.30e-04	14	93	2	28263302
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	FASN SYNM PRRC2C ASPM TANC1	6.37e-04	256	93	5	33397691
Pubmed	SYT14L, especially its C2 domain, is involved in regulating melanocyte differentiation.	RIMS1 RIMS2	7.26e-04	15	93	2	23999003
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ORC1 FASN KANSL1 AP1G2 HMGXB3 TANC1 JADE1 ZBTB42 CEP170B HTT	7.49e-04	1105	93	10	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SNIP1 TRIM66 MTUS1 ASH1L ASPM ZNF629 TEKT1 ZKSCAN2 TANC1 CEP170B	8.08e-04	1116	93	10	31753913
Pubmed	Identification of three novel genetic variations associated with electrocardiographic traits (QRS duration and PR interval) in East Asians.	SETBP1 PRDM6	8.28e-04	16	93	2	25035420
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	FASN NF1 MCM9 RALGAPB ASPM ZNF629 MTBP JADE1 VIRMA NCAPG2 HTT	8.33e-04	1327	93	11	32694731
Pubmed	Movement-related increases in subthalamic activity optimize locomotion.	CD5 HTT	9.37e-04	17	93	2	39068661
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	NLGN3 NF1 RIMS1 RIMS2 CEP170B	9.67e-04	281	93	5	28706196
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	PRRC2C BTBD10 MCM9 ASPM ZNF629 TOPBP1 CKAP2 VIRMA	9.89e-04	759	93	8	35915203
Pubmed	Functional proteomics mapping of a human signaling pathway.	SNIP1 KANSL1 ZNF484 ASH1L CILK1 ZNF83 CCDC181	1.06e-03	591	93	7	15231748
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ESYT2 FASN NF1 KANSL1 BCLAF1 RALGAPB RIMS1 VIRMA	1.12e-03	774	93	8	15302935
Pubmed	Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters.	ZNF283 ZNF222	1.30e-03	20	93	2	12743021
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SYNM SCN9A ARHGAP29 CEP170B	1.53e-03	184	93	4	32908313
Pubmed	Characterization and mapping of human genes encoding zinc finger proteins.	ZNF436 ZNF629	1.58e-03	22	93	2	1946370
Pubmed	Clustering of C2-H2 zinc finger motif sequences within telomeric and fragile site regions of human chromosomes.	ZNF436 ZNF629	1.58e-03	22	93	2	1505991
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L PRRC2C RALGAPB ZNF629 OSBPL10 TANC1 NCAPG2	1.83e-03	650	93	7	38777146
Interaction	YWHAG interactions	USP53 SNIP1 USP8 ESYT2 VPS13D NF1 MTUS1 BCLAF1 PRRC2C RALGAPB ZNF629 ARHGAP29 OSBPL10 MTBP TANC1 CKAP2 VIRMA CEP170B HTT	2.91e-06	1248	92	19	int:YWHAG
Interaction	YWHAH interactions	USP53 USP8 ESYT2 VPS13D NF1 MTUS1 PRRC2C RALGAPB ZNF629 OSBPL10 MTBP TANC1 RIMS1 RIMS2 VIRMA CEP170B HTT	8.90e-06	1102	92	17	int:YWHAH
Interaction	NOTCH2 interactions	USP53 TRIM66 ZNF594 ESYT2 ZNF142 ZNF629 ZNF624 ZNF407 ZKSCAN2 VIRMA	2.32e-05	423	92	10	int:NOTCH2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF502 ZNF717 ZNF594 ZNF142 ZNF33A ZNF484 ZNF436 ZNF283 ZNF629 ZNF343 ZNF624 ZNF407 ZKSCAN2 ZNF84 ZNF83 ZNF782 ZNF844 ZNF418 ZNF471 ZBTB42 ZNF883 PRDM6 ZNF222 ZNF345 ZNF513 ZNF2	5.56e-20	718	65	26	28
GeneFamily	Regulating synaptic membrane exocytosis family\|PDZ domain containing	RIMS1 RIMS2	7.60e-05	4	65	2	833
GeneFamily	I-set domain containing\|IgLON cell adhesion molecules	NTM OPCML	1.26e-04	5	65	2	1052
GeneFamily	PHD finger proteins	TRIM66 ASH1L JADE1	4.17e-03	90	65	3	88
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	SYNM CMYA5	4.85e-03	29	65	2	396
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	ASH1L PRDM6	6.63e-03	34	65	2	487
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP15 ARHGAP29	1.40e-02	50	65	2	721
GeneFamily	Ubiquitin specific peptidases	USP53 USP8	1.73e-02	56	65	2	366
GeneFamily	PDZ domain containing	GRIP2 RIMS1 RIMS2	1.74e-02	152	65	3	1220
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	USP53 MTUS1 PRRC2C ASH1L CILK1 GMNN	4.57e-07	138	93	6	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF717 EPS8L2 NTM ZNF407 TANC1 CEP170B	1.49e-06	169	93	6	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF717 EPS8L2 NTM ZNF407 TANC1 CEP170B	1.49e-06	169	93	6	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ORC1 ESYT2 GRIP2 PTGIS GMNN PRDM6	1.95e-06	177	93	6	4553ee8cd9c24db6511b09fe49ed11a89e7cde9e
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	USP53 ESYT2 KANSL1 MTUS1 SETBP1 ZNF83	2.94e-06	190	93	6	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	343B-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MTUS1 SETBP1 SCNN1D HEATR5A FAM131B HTT	3.13e-06	192	93	6	445985fe1bcd33e4f0a1704b27988fbfc9334538
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ORC1 ASPM MTBP CKAP2 NCAPG2 GMNN	3.22e-06	193	93	6	cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MTUS1 TANC1 RIMS1 PRDM6 OPCML MEPE	3.22e-06	193	93	6	e2b455387d1de7812305200a2041a0f4759a6f54
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	ZNF717 EPS8L2 NTM ZNF407 TANC1 CEP170B	3.32e-06	194	93	6	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	ZNF717 EPS8L2 NTM ZNF407 TANC1 CEP170B	3.32e-06	194	93	6	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ORC1 TOPBP1 MTBP NCAPG2 KIF24 GMNN	3.52e-06	196	93	6	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	severe-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZNF283 SCN9A ASPM ZNF629 NCAPG2 CEP170B	3.63e-06	197	93	6	70704b149b2820b8601d2495b7cd9cbe91eda262
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	USP53 MTUS1 BCLAF1 PRRC2C LPIN2 GMNN	3.84e-06	199	93	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(06)_OLFM4+\|World / shred by cell type by condition	USP53 MTUS1 LPIN2 OSBPL10 CILK1 GMNN	3.84e-06	199	93	6	c773b9180dbfec9c19d4098dd43332e6f6050372
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	USP53 MTUS1 BCLAF1 PRRC2C LPIN2 JADE1	3.84e-06	199	93	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	USP53 MTUS1 BCLAF1 PRRC2C OSBPL10 GMNN	3.84e-06	199	93	6	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MTUS1 SCN9A ASPM TANC1 GRIP2 MEPE	3.96e-06	200	93	6	1276bfa911fddada4235e12e3081baa53164574b
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP15 LPIN2 ZKSCAN2 TANC1 ZNF883 ZNF345	3.96e-06	200	93	6	f692b602bc989d35c9162e73dda813dbef8d5267
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ORC1 ZNF343 ZNF84 ZNF782 ZNF883	1.53e-05	149	93	5	4b44108c40376a6b73258df40d2424e68f991383
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L EPS8L2 MTUS1 LPIN2 TANC1	2.88e-05	170	93	5	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NF1 ASPM CKAP2 NCAPG2 KIF24	3.22e-05	174	93	5	72df66319f6efbd88ecf439013d97409fbf3cb52
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NF1 ASPM CKAP2 NCAPG2 KIF24	3.22e-05	174	93	5	c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ORC1 TOPBP1 ZNF407 CKAP2 GMNN	3.40e-05	176	93	5	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INTS7 TOPBP1 MTBP NCAPG2 GMNN	3.40e-05	176	93	5	9e719e6323597ecfc758c957256872cd4ae24d4d
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NLGN3 ASPM CKAP2 NCAPG2 GMNN	3.50e-05	177	93	5	3e149bff1f1b393a7abe98984e37981c8296f95d
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC82 BCLAF1 PRRC2C ASH1L ARHGAP29	3.59e-05	178	93	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD5 ASPM CKAP2 NCAPG2 GMNN	3.89e-05	181	93	5	cf13bf7a531a2d40f8d778629cf2431b684f65f3
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD5 ASPM CKAP2 NCAPG2 GMNN	3.89e-05	181	93	5	74311aac2fe27dc02a9be3bc20e0c7ef1c239049
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNIP1 CD5 ASPM CKAP2 NCAPG2	4.21e-05	184	93	5	1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNIP1 CD5 ASPM CKAP2 NCAPG2	4.21e-05	184	93	5	8578c50eaa8ce1cefc0228185c66c8e25f4bfc32
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD5 ASPM NCAPG2 KIF24 GMNN	4.32e-05	185	93	5	a3cd0511fa7cf317c3fcb7082fa785bbf51c5cef
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTM ASPM CKAP2 NCAPG2 KIF24	4.54e-05	187	93	5	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTM ASPM CKAP2 NCAPG2 KIF24	4.54e-05	187	93	5	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	NF1 KANSL1 BCLAF1 ASH1L ZNF407	4.66e-05	188	93	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	343B-Lymphocytic-ILC-ILC-1\|343B / Donor, Lineage, Cell class and subclass (all cells)	SETBP1 SCNN1D HEATR5A FAM131B HTT	4.66e-05	188	93	5	8f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCell	droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INTS7 ASPM CKAP2 NCAPG2 GMNN	4.66e-05	188	93	5	0ec2a1b0505501ba18f10a5fce68c306a6292419
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTUS1 SCN9A ASPM GRIP2 MEPE	4.66e-05	188	93	5	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD5 ASPM CKAP2 NCAPG2 GMNN	4.66e-05	188	93	5	61ae7405ab56570409bf35382dc0a038e4137c15
ToppCell	343B-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MTUS1 SETBP1 SCNN1D HEATR5A FAM131B	4.78e-05	189	93	5	c26428871dc3261327d89cacaba6e21e004ff1f3
ToppCell	PBMC-Mild-cDC_12\|Mild / Compartment, Disease Groups and Clusters	ORC1 ASPM TANC1 NCAPG2 GMNN	4.78e-05	189	93	5	946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SCN9A OSBPL10 TANC1 GRIP2 MEPE	4.90e-05	190	93	5	d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNM NTM SCN9A GRIP2 PTGIS	4.90e-05	190	93	5	1803b1e7c36285f9eaabc3c6e9a9752c5908db3d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTUS1 SCN9A ASPM GRIP2 MEPE	4.90e-05	190	93	5	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ASPM RIMS1 NCAPG2 GMNN OPCML	4.90e-05	190	93	5	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTUS1 SCN9A ASPM TANC1 GRIP2	4.90e-05	190	93	5	e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.02e-05	191	93	5	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L CCDC82 SETBP1 RALGAPB OSBPL10	5.28e-05	193	93	5	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SCN9A ASPM TANC1 GRIP2 MEPE	5.28e-05	193	93	5	5581a5ebcd21a2a8062ccfb917f088ec67a10a9c
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ORC1 ASPM CKAP2 NCAPG2 KIF24	5.41e-05	194	93	5	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	(1)_T_cells_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ORC1 CD5 ASPM CKAP2 GMNN	5.41e-05	194	93	5	8f313071933451780309d2174ed27d8cdc734343
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ASPM ZNF844 ZBTB42 GMNN ZNF222	5.41e-05	194	93	5	8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TANC1 RIMS1 PRDM6 OPCML MEPE	5.41e-05	194	93	5	fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NLGN3 ZNF33A RIMS2 XPO7	5.54e-05	99	93	4	a815a887094204de30b299e8907e81ad9a39c016
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ORC1 MTBP NCAPG2 KIF24 GMNN	5.54e-05	195	93	5	cec7df321f372d05c94f97d6bb18891a5cc3dec3
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ASPM TOPBP1 CKAP2 NCAPG2 GMNN	5.54e-05	195	93	5	c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCell	facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS7 ASPM CKAP2 NCAPG2 GMNN	5.54e-05	195	93	5	93c345e70d6c8ff5d12fd63d73228c1700b804a0
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ORC1 MTBP NCAPG2 KIF24 GMNN	5.54e-05	195	93	5	b65463a804fed2d9a3be9e528ca8b9c98469bc86
ToppCell	(1)_T_cells-(1)_T_cells_Dividing\|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ORC1 ASPM CKAP2 KIF24 GMNN	5.54e-05	195	93	5	cf00a0b4f341f0487d5b37810abe2952fdd3f6f2
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L MUC16 CATSPER3 RIMS1 RIMS2	5.54e-05	195	93	5	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.54e-05	195	93	5	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|343B / Donor, Lineage, Cell class and subclass (all cells)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.54e-05	195	93	5	47a01b8a92eebeb34ac7f70bf1ab4613a326e24f
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.68e-05	196	93	5	6d80e23f6a1725a3f5ea7263233c55c2ea56f977
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.68e-05	196	93	5	bf1d3fae8c01bb3d17c2dafad92b94937c663acd
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.68e-05	196	93	5	3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.68e-05	196	93	5	4f649e3bfd21f21682678828673843a7d51c4ff2
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.68e-05	196	93	5	799c290fb3dfacb666dd0dc3c43ec8a86b697ec7
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.68e-05	196	93	5	0c003a767c3b58605099dab64b9df0d8e5d8bc4b
ToppCell	Control-Myeloid-proliferating_Myeloid_cells\|Control / Disease group,lineage and cell class （2021.01.30）	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.82e-05	197	93	5	ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e
ToppCell	Transverse-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	ESYT2 MUC16 ZNF407 HEATR5A ZNF513	5.82e-05	197	93	5	a0a096e8e80763a92d5d7396eb678a4587771a3a
ToppCell	(3)_DC_Monocyte_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.96e-05	198	93	5	e2b89f6d7c0007ccab62495cd543fe0e5513a9a4
ToppCell	distal-Hematologic-Proliferating_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.96e-05	198	93	5	2b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ORC1 ASPM CKAP2 NCAPG2 KIF24	5.96e-05	198	93	5	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ORC1 ASPM CKAP2 NCAPG2 GMNN	5.96e-05	198	93	5	281fc2536cdc4c717b30de156e563c0e4baba99d
ToppCell	COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	ORC1 ASPM TANC1 NCAPG2 KIF24	6.10e-05	199	93	5	e222b90caf45904d8f763574e7b6aac13333df92
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ORC1 ASPM TOPBP1 NCAPG2 GMNN	6.10e-05	199	93	5	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ORC1 FASN ASPM NCAPG2 GMNN	6.10e-05	199	93	5	4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_Tem\|Int-URO / Disease, condition lineage and cell class	USP53 EPS8L2 CD5 ARHGAP15 SYNM	6.10e-05	199	93	5	c55634d4b66ab4e3f9262a83d993ea0c5f01ea61
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MCM9 ASPM CKAP2 NCAPG2 KIF24	6.10e-05	199	93	5	c6d59ed26eadd3c41acfe1b4d929270e00ea3e95
ToppCell	COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Severe / Disease group, lineage and cell class	ORC1 ASPM TOPBP1 NCAPG2 GMNN	6.10e-05	199	93	5	ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ORC1 ASPM TOPBP1 NCAPG2 GMNN	6.10e-05	199	93	5	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NTM ASPM CKAP2 NCAPG2 KIF24	6.10e-05	199	93	5	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ORC1 ASPM NCAPG2 KIF24 GMNN	6.10e-05	199	93	5	f9bf94ab6b5b134f5b98a65340843b147941ab58
ToppCell	distal-Hematologic-Proliferating_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	3835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCell	distal-2-Hematologic-Proliferating_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	EPS8L2 MTUS1 AP1G2 HEATR5A CEP170B	6.25e-05	200	93	5	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Severe / Disease, condition lineage and cell class	ORC1 ASPM TOPBP1 NCAPG2 GMNN	6.25e-05	200	93	5	0892603e604c2a945dd720685d45970f855bd5d3
ToppCell	LAM-Myeloid-pMacrophage\|LAM / Condition, Lineage and Cell class	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	7e233d037165c9d3607604aaaf0f368e266567d3
ToppCell	NS-critical-d_07-13-Lymphoid-NKT-proliferating\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29
ToppCell	Biopsy_Other_PF-Immune-Proliferating_Macrophages\|Biopsy_Other_PF / Sample group, Lineage and Cell type	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	61473e8613f39a92002d5b631e6bd563735566e4
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ORC1 ASPM TOPBP1 NCAPG2 GMNN	6.25e-05	200	93	5	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	COVID-19-Lymphoid-Proliferating_CD8_T_cells\|COVID-19 / Condition, Lineage and Cell class	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	b239c711cce967826432fdbd5f88eba98a88bb0c
ToppCell	(3)_MNP-(3)_DC_Monocyte_Dividing\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	d94fe9bd6ee7c1fed14666f24de41bda014e299b
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ORC1 ASPM TOPBP1 NCAPG2 GMNN	6.25e-05	200	93	5	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	critical-Lymphoid-NKT-proliferating\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ORC1 ASPM CKAP2 NCAPG2 GMNN	6.25e-05	200	93	5	d698458b90bf8256fe664618ef27620aa910b02a
ToppCell	mild-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ORC1 ASPM TOPBP1 NCAPG2 GMNN	6.25e-05	200	93	5	63cc57b9331459efbb73051d174d198a3568b938
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ASPM CKAP2 NCAPG2 KIF24	1.79e-04	134	93	4	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	NLGN3 CMYA5 OPCML ZNF2	1.95e-04	137	93	4	a69976938d4e89315ec0be3a332b91ddf3799d65
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ORC1 RIMS1 KIF24 GMNN	2.06e-04	139	93	4	c9bf98bed77415a1438f3f9e441a1346e75c26b0
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ORC1 ESYT2 ARHGAP29 HEATR5A	2.36e-04	144	93	4	57d2846ec26d4490ec11c171af447b17a729437e
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	USP8 CD5 MTBP CMYA5	2.55e-04	147	93	4	b2196046656157d7fcf5b5d1cec7bf521b1e5d8e
Disease	Liposarcoma, Pleomorphic	FASN NF1	5.26e-05	4	88	2	C0205825
Disease	Malignant neoplasm of ovary	FASN KANSL1 FAM107A MUC16 OPCML	5.77e-05	137	88	5	C1140680
Disease	biological sex	ARHGAP15 NTM SETBP1 RIMS2 OPCML XPO7	6.68e-05	230	88	6	PATO_0000047
Disease	alcohol consumption measurement	SECISBP2L TRIM66 NF1 KANSL1 ARHGAP15 NTM SETBP1 ZSWIM2 JADE1 RIMS2 OPCML HTT XPO7	7.80e-05	1242	88	13	EFO_0007878
Disease	Liposarcoma, Dedifferentiated	FASN NF1	1.31e-04	6	88	2	C0205824
Disease	liposarcoma	FASN NF1	1.31e-04	6	88	2	C0023827
Disease	Liposarcoma, well differentiated	FASN NF1	1.31e-04	6	88	2	C1370889
Disease	Patent ductus arteriosus	PTGIS PRDM6	1.31e-04	6	88	2	C0013274
Disease	Patent Ductus Arteriosus Familial	PTGIS PRDM6	1.31e-04	6	88	2	C2936170
Disease	EAR, PATELLA, SHORT STATURE SYNDROME	ORC1 GMNN	1.83e-04	7	88	2	C1868684
Disease	Intellectual Disability	FASN ZNF142 NF1 KANSL1 SETBP1 ASH1L HTT	3.86e-04	447	88	7	C3714756
Disease	ovarian neoplasm	FASN KANSL1 MUC16 OPCML	7.06e-04	134	88	4	C0919267
Disease	Mental Retardation, Psychosocial	FASN NF1 KANSL1 SETBP1	8.09e-04	139	88	4	C0025363
Disease	Profound Mental Retardation	FASN NF1 KANSL1 SETBP1	8.09e-04	139	88	4	C0020796
Disease	Mental deficiency	FASN NF1 KANSL1 SETBP1	8.09e-04	139	88	4	C0917816
Disease	autism spectrum disorder (implicated_via_orthology)	NLGN3 ASH1L RIMS1 RIMS2	1.13e-03	152	88	4	DOID:0060041 (implicated_via_orthology)
Disease	Chronic myeloproliferative disorder	ORC1 GMNN	1.45e-03	19	88	2	C1292778
Disease	Juvenile Myelomonocytic Leukemia	NF1 SETBP1	1.45e-03	19	88	2	C0349639
Disease	Seckel syndrome	ORC1 GMNN	1.95e-03	22	88	2	C0265202
Disease	Hepatitis	NTM ARHGAP29	1.95e-03	22	88	2	HP_0012115
Disease	sudden cardiac arrest	CCDC179 AP1G2 TANC1	1.98e-03	83	88	3	EFO_0004278
Disease	Dwarfism	ORC1 GMNN	2.52e-03	25	88	2	C0013336
Disease	ergothioneine measurement	RIMS2 OPCML	2.73e-03	26	88	2	EFO_0021163
Disease	Neurodevelopmental Disorders	SETBP1 ASH1L RIMS1	2.74e-03	93	88	3	C1535926

Protein segments in the cluster

Peptide	Gene	Start	Entry
HQHSAQVKRPSVSKE	ESYT2	666	A0FGR8
TSPTRQHHVEREKDH	BTBD10	91	Q9BSF8
RHKHREHRSSEQPQV	ASH1L	1486	Q9NR48
HQRHSRVISSSPVDT	CATSPER3	6	Q86XQ3
LVQSDHSAVQRHRPT	AP1G2	336	O75843
RNHTATVRSHAENPT	CD5	431	P06127
NIVHPTLSHDTRRSK	LINC02910	56	Q8N268
VSAREQSSERQHHPL	CEP170B	1001	Q9Y4F5
QDISSHSHNKQPKRR	ASPM	476	Q8IZT6
PIRSHHSNTRDTVKQ	CKAP2	256	Q8WWK9
NPVKASRSHQELHRE	FAM107A	36	O95990
SIIPERKNAHHSIRQ	INTS7	131	Q9NVH2
PHSVRTLRTTENHPK	MUC16	1341	Q8WXI7
SPVKSKSTHRIQHNI	MEPE	206	Q9NQ76
SVQTDNHPKTSRVHL	NTM	116	Q9P121
NHPKTSRVHLIVQVS	NTM	121	Q9P121
TTHSKNASHRVPRTT	MTUS1	591	Q9ULD2
TEHSIQHPVTKTATR	HMGXB3	1156	Q12766
QHPVTKTATRRIVHA	HMGXB3	1161	Q12766
QEHTHTPFRQSKLTQ	KIF24	491	Q5T7B8
LTTAKLSHHQTRPDR	KANSL1	731	Q7Z3B3
VSRQSIRNSQKHSPT	EPS8L2	451	Q9H6S3
AVQPQHSHESVRRDT	FAM131B	96	Q86XD5
PEQQRTTHHRSRSVS	RIMS1	941	Q86UR5
LRNHVVTHSSDRPFK	PRDM6	516	Q9NQX0
SVQTDNHPKTSRVHL	OPCML	116	Q14982
RTDSLRKQHHLDPSS	RIMS2	481	Q9UQ26
RKQHHLDPSSAVRKT	RIMS2	486	Q9UQ26
AKAQNEATSTPHRIR	ORC1	366	Q13415
DTTHSSHITRRPNGK	NLGN3	651	Q9NZ94
RSTNNVERHTPRTKI	ARHGAP29	1001	Q52LW3
KSNHRTQSAHISPVT	CCDC181	316	Q5TID7
RHETRRNSKSHVPEQ	CCDC82	6	Q8N4S0
KLSVDRVNVHSPHRA	HTT	2901	P42858
VQRHKNHRQPLKTTT	HEATR5A	1406	Q86XA9
STSQPSLRHKVNEHE	CUSTOS	56	Q96C57
EHSTRQKSPEIHRRI	BCLAF1	641	Q9NYF8
LTPERHTVHTIQTSK	CMYA5	2841	Q8N3K9
ELIISRKPHTAHSSR	GRIP2	1016	Q9C0E4
RVTAIHIDPATHRQK	FASN	1051	P49327
LPHQSHRQRSSLAKI	SCNN1D	651	P51172
HHPSEVTERQLANKR	CCDC179	21	H3BU77
HHHVTSRKPQTERSL	MTBP	771	Q96DY7
RKHRNDHLTSTTSSP	GMNN	51	O75496
EPNRSTSRKHSAQHK	MCM9	721	Q9NXL9
HVSRKSEHLSVRPQT	MRPS23	146	Q9Y3D9
RNRSPHHSTVKVKQE	SNIP1	96	Q8TAD8
QHRRTKQPQENTTHV	SYNM	801	O15061
LPRTHESQAQDRVHS	PTGIS	186	Q16647
KVTEPISRHRRNHSQ	ARHGAP15	51	Q53QZ3
RKRSVSHGSNHTQKP	PRRC2C	921	Q9Y520
HRRAHEKRLSTPNQS	SCN9A	521	Q15858
PVHSQENRITKTVSH	TANC1	1811	Q9C0D5
KVAHTRLETRTHRPN	TEKT1	311	Q969V4
RPDNKHLSSSQSHRS	SECISBP2L	366	Q93073
SHKPLRSTDVSQRHL	JADE1	681	Q6IE81
VHRVTAEVKHNPTNT	OSBPL10	636	Q9BXB5
PAKPHTRISSRQHQA	CILK1	326	Q9UPZ9
ITAVQSRHTDTPVHR	NCAPG2	991	Q86XI2
QHSREKALPSDNIRH	USP53	86	Q70EK8
VNLTRHTRTHTGEKP	ZNF513	191	Q8N8E2
SQLTVHQRRHTGEKP	ZNF624	681	Q9P2J8
SNLIRHQRTHSNEKP	ZNF343	506	Q6P1L6
SSLTRHQRTHTGEKP	ZNF2	186	Q9BSG1
SDLNRHQKTHTGDRP	ZNF436	151	Q9C0F3
TQRISSSQQHPHLRK	NF1	2581	P21359
SSQQHPHLRKVSVSE	NF1	2586	P21359
IHSSHVRQDSPTKRP	SGSM1	206	Q2NKQ1
PHNRRHRAVTVNKAT	RALGAPB	381	Q86X10
SSLNRHIRADTAHKP	ZNF844	116	Q08AG5
SQLTSHQRTHTGEKP	ZNF84	276	P51523
SHLTRHQRVHTGQKP	ZNF33A	341	Q06730
SHLSRQPVSHSVNTK	ZSWIM2	606	Q8NEG5
NLSRHTVVHTREKPH	ZBTB42	376	B2RXF5
SRLTVHQRTHTGEKP	ZNF717	436	Q9BY31
SSRTVHQRIHTGEKP	ZNF471	416	Q9BX82
SSLLRHQKTHTAERP	ZNF418	551	Q8TF45
STPLTKHQRIHTGER	ZNF502	391	Q8TBZ5
EINQADTTHPLTKHR	XPO7	161	Q9UIA9
IVHVNTHLVSSRKRP	ZNF484	161	Q5JVG2
RQQVSSPVHREKHSP	ZKSCAN2	131	Q63HK3
SDLIRHQVTHTREKP	ZNF594	581	Q96JF6
RNSTLPVHQRTHATD	ZNF782	321	Q6ZMW2
TSLIRHQRTHTGEKP	ZNF883	306	P0CG24
SSETALKQHALRRHP	ZNF142	1296	P52746
PTFSIQHQRIHTDEK	ZNF345	46	Q14585
PLKSRVSHGNEVRHS	ZNF407	686	Q9C0G0
SELTQHQRTHTGEKP	ZNF629	331	Q9UEG4
VALTRHQETHTQEKP	ZNF629	781	Q9UEG4
QHSSPNVVRKHSTSL	TRIM66	616	O15016
PSDTSTKNRHGHRQK	SETBP1	906	Q9Y6X0
DTAEHPGTRLQTHRK	TOPBP1	761	Q92547
KHPSAEQSSHIDVVR	VIRMA	16	Q69YN4
HRIKSESTNHEQQSP	USP8	421	P40818
PQRISSTVKTHISHT	ZNF83	56	P51522
SRLQTHQRVHTGEKP	ZNF222	186	Q9UK12
SKSLTPHQRIHNTEK	ZNF283	191	Q8N7M2
KKQNHVTPSRHRNSS	VPS13D	2421	Q5THJ4
SKRERSDHHPRTATI	LPIN2	276	Q92539